Background National Comprehensive Cancer Network guidelines consider 18 F-fluciclovine
PET-CT for prostate cancer biochemical recurrence localisation after radical prostatectomy, …

Prostate cancer is biologically and clinically a heterogeneous disease that makes imaging
evaluation challenging. The role of imaging in prostate cancer should include diagnosis, …

THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …

It is hoped that in the not too distant future, noninvasive imaging–based molecular
interrogation and characterization of tumors can improve our fundamental understanding of the …

PURPOSE: To evaluate the pattern and degree of incidental colonic fluorodeoxyglucose (FDG)
uptake in patients without colorectal carcinoma who underwent whole-body FDG …

Multimodality imaging has made great strides in the imaging evaluation of patients with a
variety of diseases. Positron emission tomography/computed tomography (PET/CT) is now …

We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information that …

Prostate-specific membrane antigen (PSMA) is a promising target for imaging diagnostics
and targeted radionuclide therapy (theranostics) of prostate cancer and its metastases. There …

Prostate cancer is a major public health problem in developed countries. The remarkable
biological and clinical heterogeneity of prostate cancer provides unique opportunities as well …

The use of positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) in
prostate cancer depends on the phase of the disease along the natural history of this prevalent …